Sorrento Therapeutics (SRNE) Jumps: Stock Adds 9.1% in Session

Zacks Equity Research

Sorrento Therapeutics, Inc. (SRNE) was a big mover last session, as its shares rose over 9% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company, as the stock is now up nearly 21% in the past one-month timeframe.

In the last 30-day frame, the company did not witness any estimate revision while the Zacks Consensus Estimate moved lower. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Sorrento currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Other better-ranked stocks in the medical sector include Grifols, S.A. (GRFS), Endocyte, Inc. (ECYT) and Lannett Company, Inc. (LCI). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




SORRENTO THERAPEUTICS INC (SRNE): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report

GRIFOLS SA ADS (GRFS): Free Stock Analysis Report

ENDOCYTE INC (ECYT): Free Stock Analysis Report


Zacks Investment Research